Search stocks

Find any stock by ticker or company name

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

MCK - McKesson Corporation So'nggi Yangiliklar | Finranks

Home

/

MCK

M

McKesson Corporation (MCK)

NYQ – Real vaqt narxi. Valyuta: USD

884.74

-17.03 (-1.89%)

Bozor ochiq: Aug 12, 2026, 2:08 PM EDT

900.93

-0.84 (-0.09%)

Oldingi bozordan keyin: Aug 11, 2026, 7:56 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Here's Why McKesson (MCK) is a Strong Momentum Stock

Here's Why McKesson (MCK) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

McKesson Q1 Earnings Call Highlights

McKesson Q1 Earnings Call Highlights

McKesson NYSE: MCK reported fiscal first-quarter 2027 results that exceeded its expectations, citing broad-based momentum across its operating businesses and prompting the healthcare services company to raise its full-year adjusted earnings outlook.

McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)

McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)

McKesson delivered strong Q1 results, with EPS up 20% and revenues rising 7.7% while modestly raising FY27 EPS guidance. I see GLP-1-driven momentum decelerating alongside a broader dip in the company's top-line growth profile. The Wellverse spin-off and prior divestitures are streamlining MCK, potentially justifying a premium multiple versus peers.

McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

McKesson (MCK) could produce exceptional returns because of its solid growth attributes.

MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised

MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised

McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.

MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise

MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise

McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand, oncology growth and disciplined spending shape the call.

Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Videolar

No Data

There is no data to display

Press-relizlar

McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance

McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2027 first quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 5 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and ar.